Publications
Clinical Performance of the Updated Trabecular Bone Score (TBS) Algorithm, Which Accounts for the Soft Tissue Thickness: The OsteoLaus Study.
Shevroja E, Aubry-Rozier B, Hans G, Rodriguez EG, Stoll D, Lamy O, Hans D
J Bone Miner Res. 2019 Dec;34(12):2229-2237
The Metabolic Benefits of Menopausal Hormone Therapy Are Not Mediated by Improved Nutritional Habits. The OsteoLaus Cohort.
Papadakis GE, Hans D, Gonzalez Rodriguez E, Vollenweider P, Waeber G, Marques-Vidal P, Lamy O
Nutrients. 2019 Aug 16;11(8)
[How to manage the rebound effect at denosumab discontinuation and avoid multiple vertebral fractures?]
Gonzalez Rodriguez E, Lamy O, Aubry-Rozier B, Stoll D, Uebelhart B
Rev Med Suisse. 2019 Apr 17;15(647):831-835
Stopping Denosumab.
Lamy O, Stoll D, Aubry-Rozier B, Rodriguez EG
Curr Osteoporos Rep. 2019 Feb;17(1):8-15
Menopausal Hormone Therapy Is Associated With Reduced Total and Visceral Adiposity: The OsteoLaus Cohort.
Papadakis GE, Hans D, Rodriguez EG, Vollenweider P, Waeber G, Marques-Vidal P, Lamy O
J Clin Endocrinol Metab. 2018 May 1;103(5):1948-1957
Quand le silence prend patients, médecins et assureurs-maladie à contre-pied
Lamy, O.
In Forum Médical Suisse (Vol. 18, No. 08, pp. 167-167). EMH Media.
Impact of a fracture liaison service on patient management after an osteoporotic fracture: the CHUV FLS.
Aubry-Rozier B, Stoll D, Gonzalez Rodriguez E, Hans D, Prudent V, Seuret A, Farron A, Lamy O
Swiss Med Wkly. 2018;148:w14579
High Evening Cortisol Level Is Associated With Low TBS and Increased Prevalent Vertebral Fractures: OsteoLaus Study.
Gonzalez Rodriguez E, Lamy O, Stoll D, Metzger M, Preisig M, Kuehner C, Vollenweider P, Marques-Vidal P, Waeber G, Aubry-Rozier B, Hans D
J Clin Endocrinol Metab. 2017 Jul 1;102(7):2628-2636
Clinical Features of 24 Patients With Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases.
Anastasilakis AD, Polyzos SA, Makras P, Aubry-Rozier B, Kaouri S, Lamy O
J Bone Miner Res. 2017 Jun;32(6):1291-1296
The lumbar spine age-related degenerative disease influences the BMD not the TBS: the Osteolaus cohort.
Padlina I, Gonzalez-Rodriguez E, Hans D, Metzger M, Stoll D, Aubry-Rozier B, Lamy O
Osteoporos Int. 2017 Mar;28(3):909-915
Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: 9 Clinical Cases Report.
Lamy O, Gonzalez-Rodriguez E, Stoll D, Hans D, Aubry-Rozier B
J Clin Endocrinol Metab. 2017 Feb 1;102(2):354-358
A Meta-Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAX.
McCloskey EV, Odén A, Harvey NC, Leslie WD, Hans D, Johansson H, Barkmann R, Boutroy S, Brown J, Chapurlat R, Elders PJM, Fujita Y, Glüer CC, Goltzman D, Iki M, Karlsson M, Kindmark A, Kotowicz M, Kurumatani N, Kwok T, Lamy O, Leung J, Lippuner K, Ljunggr
J Bone Miner Res. 2016 May;31(5):940-8
Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports.
Aubry-Rozier B, Gonzalez-Rodriguez E, Stoll D, Lamy O
Osteoporos Int. 2016 May;27(5):1923-5
The benefit of menopausal hormone therapy on bone density and microarchitecture persists after its withdrawal.
Papadakis, G., Hans, D., Gonzalez-Rodriguez, E., Vollenweider, P., Waeber, G., Marques-Vidal, P. M., & Lamy, O.
The Journal of Clinical Endocrinology & Metabolism, 101(12), 5004-5011.
Rue du Bugnon 46
1011 Lausanne
+41 21 314 9548
Rue du Bugnon 46
1011 Lausanne
+41 21 314 9548